ANTI-PLATELET ACTION OF INTRAVENOUS-INFUSION OF PROSTACYCLIN IN MAN

[1] COMPARISON OF VASODEPRESSOR EFFECTS OF PROSTACYCLIN AND 6-OXO-PROSTAGLANDIN F-1-ALPHA WITH THOSE OF PROSTAGLANDIN-E2 IN RATS AND RABBITS [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1978, 62 (01) : 125 - 130

[2] PROSTACYCLIN INCREASES CYCLIC-AMP LEVELS AND ADENYLATE-CYCLASE ACTIVITY IN PLATELETS [J]. NATURE, 1977, 267 (5614) : 850 - 851

[3] ARTERIAL-WALLS GENERATE FROM PROSTAGLANDIN ENDOPEROXIDES A SUBSTANCE (PROSTAGLANDIN-X) WHICH RELAXES STRIPS OF MESENTERIC AND CELIAC ARTERIES AND INHIBITS PLATELET-AGGREGATION [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1976, 12 (06) : 897 - 913

[4] GENERATION OF PROSTACYCLIN BY ARTERIES AND BY CORONARY VASCULAR BED IS REDUCED IN EXPERIMENTAL ATHEROSCLEROSIS IN RABBITS [J]. PROSTAGLANDINS, 1977, 14 (06): : 1025 - 1034

[5] DOUGHERTY JH, 1977, LANCET, V1, P821

[6] PROSTACYCLIN (PGX) IS ENDOGENOUS METABOLITE RESPONSIBLE FOR RELAXATION OF CORONARY-ARTERIES INDUCED BY ARACHIDONIC-ACID [J]. PROSTAGLANDINS, 1977, 13 (01): : 3 - 15

[7] DUSTING GJ, 1978, P BRIT PHARMAC 0104, P69

[8] GAETANO G, 1971, INT J CLIN PHARM TH, V5, P196

[9] MODULATION OF HUMAN PLATELET ADENYLATE-CYCLASE BY PROSTACYCLIN (PGX) [J]. PROSTAGLANDINS, 1977, 13 (03): : 377 - 388

[10] INVIVO METHOD FOR QUANTITATION OF ANTI-PLATELET POTENCY OF DRUGS [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1978, 302 (01) : 25 - 30

[1] COMPARISON OF VASODEPRESSOR EFFECTS OF PROSTACYCLIN AND 6-OXO-PROSTAGLANDIN F-1-ALPHA WITH THOSE OF PROSTAGLANDIN-E2 IN RATS AND RABBITS [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1978, 62 (01) : 125 - 130

[2] PROSTACYCLIN INCREASES CYCLIC-AMP LEVELS AND ADENYLATE-CYCLASE ACTIVITY IN PLATELETS [J]. NATURE, 1977, 267 (5614) : 850 - 851

[3] ARTERIAL-WALLS GENERATE FROM PROSTAGLANDIN ENDOPEROXIDES A SUBSTANCE (PROSTAGLANDIN-X) WHICH RELAXES STRIPS OF MESENTERIC AND CELIAC ARTERIES AND INHIBITS PLATELET-AGGREGATION [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1976, 12 (06) : 897 - 913

[4] GENERATION OF PROSTACYCLIN BY ARTERIES AND BY CORONARY VASCULAR BED IS REDUCED IN EXPERIMENTAL ATHEROSCLEROSIS IN RABBITS [J]. PROSTAGLANDINS, 1977, 14 (06): : 1025 - 1034

[5] DOUGHERTY JH, 1977, LANCET, V1, P821

[6] PROSTACYCLIN (PGX) IS ENDOGENOUS METABOLITE RESPONSIBLE FOR RELAXATION OF CORONARY-ARTERIES INDUCED BY ARACHIDONIC-ACID [J]. PROSTAGLANDINS, 1977, 13 (01): : 3 - 15

[7] DUSTING GJ, 1978, P BRIT PHARMAC 0104, P69

[8] GAETANO G, 1971, INT J CLIN PHARM TH, V5, P196

[9] MODULATION OF HUMAN PLATELET ADENYLATE-CYCLASE BY PROSTACYCLIN (PGX) [J]. PROSTAGLANDINS, 1977, 13 (03): : 377 - 388

[10] INVIVO METHOD FOR QUANTITATION OF ANTI-PLATELET POTENCY OF DRUGS [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1978, 302 (01) : 25 - 30